Revenue | ₹1,128.42Cr |
Net Profits | ₹99.61Cr |
Net Profit Margins | 8.83% |
Strides Pharma Science Ltd’s revenue fell -74.08% since last year same period to ₹1,128.42Cr in the Q1 2025-2026. On a quarterly growth basis, Strides Pharma Science Ltd has generated -6.39% fall in its revenue since last 3-months.
Strides Pharma Science Ltd’s net profit fell -97.03% since last year same period to ₹99.61Cr in the Q1 2025-2026. On a quarterly growth basis, Strides Pharma Science Ltd has generated 21.19% jump in its net profits since last 3-months.
Strides Pharma Science Ltd’s net profit margin fell -88.53% since last year same period to 8.83% in the Q1 2025-2026. On a quarterly growth basis, Strides Pharma Science Ltd has generated 29.47% jumped in its net profit margins since last 3-months.
The revenue for Strides Pharma Science Ltd in the Q1 results 2025 was ₹1,128.42Cr.
The net profit for Strides Pharma Science Ltd in the Q1 results 2025 was ₹99.61Cr.
The net profit margin for Strides Pharma Science Ltd in the Q1 results 2025 was 8.83%.
The revenue for Strides Pharma Science Ltd in the Q1 results 2024 was ₹4,353.54Cr.
The net profit for Strides Pharma Science Ltd in the Q1 results 2024 was ₹3,351.47Cr.
The net profit margin for Strides Pharma Science Ltd in the Q1 results 2024 was 76.98%.